Title : SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET.

Pub. Date : 2020 Apr

PMID : 32111984






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition, SOX13 was shown to be a direct target of HGF/STAT3 signaling, and the c-MET inhibitor crizotinib blocked the HGF/STAT3/SOX13/c-MET axis, significantly inhibiting SOX13-mediated CRC migration, invasion and metastasis. Crizotinib SRY-box transcription factor 13 Homo sapiens
2 In addition, SOX13 was shown to be a direct target of HGF/STAT3 signaling, and the c-MET inhibitor crizotinib blocked the HGF/STAT3/SOX13/c-MET axis, significantly inhibiting SOX13-mediated CRC migration, invasion and metastasis. Crizotinib SRY-box transcription factor 13 Homo sapiens
3 In summary, SOX13 is a promising prognostic biomarker in patients with CRC, and blocking the HGF/STAT3/SOX13/c-MET axis with crizotinib could be a new therapeutic strategy to prevent SOX13-mediated CRC metastasis. Crizotinib SRY-box transcription factor 13 Homo sapiens
4 In summary, SOX13 is a promising prognostic biomarker in patients with CRC, and blocking the HGF/STAT3/SOX13/c-MET axis with crizotinib could be a new therapeutic strategy to prevent SOX13-mediated CRC metastasis. Crizotinib SRY-box transcription factor 13 Homo sapiens